Among patients with a high risk of recurrence of a gastrointestinal stromal tumor following surgery for its removal, patients who received imatinib (a drug to treat certain cancers) for 3 years instead of 1 had improved recurrence-free survival and overall survival, according to a study in the March 28 issue of JAMA.
- Mayo Clinic identifies best treatments for long-term survival in brain tumor patientsWed, 3 Dec 2008, 17:19:13 EST
- Stage II and stage III colon cancer patients treated after 1995 have improved overall survivalThu, 3 Jun 2010, 17:56:44 EDT
- After resection, common treatment of pancreatic cancer as effective as chemotherapy drug doseTue, 7 Sep 2010, 17:08:37 EDT
- Limited lymph node removal for certain breast cancer does not appear to result in poorer survivalTue, 8 Feb 2011, 16:34:18 EST
- Chemotherapy after gastric cancer surgery appears to provide survival benefitTue, 4 May 2010, 17:58:34 EDT